MedTrace Logo

Validation of the GIDS and Description of Phosphate Disorders

NCT05909722 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2681

Last updated 2025-03-25

No results posted yet for this study

Summary

This study will address two specific research questions simultaneously:

1. validation of the GastroIntestinal (GI) Dysfunction score (GIDS).
2. description of epidemiology, risk factors, and management of phosphate disorders.

The aim is to recruit 20 ICUs and 1500 ICU patients. Sites will recruit all consecutive adult patients to a maximum of 120 patients or a maximum recruitment period of 8 weeks, whichever comes first. Daily data collection on gastrointestinal signs and symptoms as well as phosphate values and management will be collected during ICU stay for maximum of 7 days. 28 and 90 day mortality and days free of organ support will be the main outcomes. Secondary outcomes include prevalence of hypo- and hyperphosphatemia and description of their management.

Conditions

  • Organ Dysfunction Scores
  • Hypophosphatemia

Interventions

DIAGNOSTIC_TEST

Gastrointestinal Dysfunction Score will be calculated

We collect routine daily data on GI signs and symptoms and calculate the score (GIDS). We collect serum phosphate values as measured in routine practice of participating sites.

Sponsors & Collaborators

  • University of Tartu

    lead OTHER

Principal Investigators

  • Arthur van Zanten, PhD · Gelderse Valley Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-08
Primary Completion
2024-12-20
Completion
2024-12-20

Countries

  • Estonia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05909722 on ClinicalTrials.gov